# Trial Onset Comprehensive Results (sacc alignment)

## Summary

### monkey_M_FEF_vs_LIP_saccade_summary
- **Monkey**: M
- **Areas**: FEF vs LIP
- **Feature**: saccade (S)
- **Alignment**: sacc
- **QC threshold**: 0.75
- **Sessions** (8): 20200328, 20200926, 20200929, 20201001, 20201004, 20201204, 20201211, 20201216
- **N trials**: 542
- **Median dt**: 55.0 ms
- **Mean dt**: 60.4 ms
- **p (two-sided)**: 5e-05
- **p (area2 later)**: 5e-05

### monkey_M_SC_vs_FEF_saccade_summary
- **Monkey**: M
- **Areas**: SC vs FEF
- **Feature**: saccade (S)
- **Alignment**: sacc
- **QC threshold**: 0.75
- **Sessions** (1): 20201211
- **N trials**: 98
- **Median dt**: -57.5 ms
- **Mean dt**: -54.1 ms
- **p (two-sided)**: 5e-05
- **p (area2 later)**: 1

### monkey_M_SC_vs_LIP_saccade_summary
- **Monkey**: M
- **Areas**: SC vs LIP
- **Feature**: saccade (S)
- **Alignment**: sacc
- **QC threshold**: 0.75
- **Sessions** (1): 20201211
- **N trials**: 63
- **Median dt**: 10.0 ms
- **Mean dt**: 8.8 ms
- **p (two-sided)**: 0.246
- **p (area2 later)**: 0.1265

### monkey_S_SC_vs_LIP_saccade_summary
- **Monkey**: S
- **Areas**: SC vs LIP
- **Feature**: saccade (S)
- **Alignment**: sacc
- **QC threshold**: 0.75
- **Sessions** (1): 20231025
- **N trials**: 60
- **Median dt**: -5.0 ms
- **Mean dt**: 5.9 ms
- **p (two-sided)**: 0.5738
- **p (area2 later)**: 0.2868

